<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01553760</url>
  </required_header>
  <id_info>
    <org_study_id>0163-11-MMC</org_study_id>
    <nct_id>NCT01553760</nct_id>
  </id_info>
  <brief_title>The Use of an Anterior Chamber Maintainer as a Sole Fluid Source in Micro Incision Cataract Surgery as Compared to a Standard Phacoemulsification Procedure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the use of an Anterior Chamber Maintainer (ACM) as
      the sole fluid source in phacoemulsification micro incision cataract surgery (using 1.1mm
      corneal incision) as opposed to conventional coaxial phacoemulsification (using 2.4mm corneal
      incision).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three-port Micro Incision Cataract Surgery (Tri-MICS) is a technique suggested by Professor
      Assia. The idea (principle) behind the Tri-MICS technique is the use of a sleeveless phaco
      needle which is introduced via a tiny incision (1.1mm). An additional corneal incision is
      made for the introduction of a second surgical instrument, and a third for an ACM as an
      exclusive source for the infusion - this saves the need for an additional instrument. The ACM
      that will be used in this study (AVI New York) is a small metal tube with an external
      diameter of 1.1 mm, and an internal diameter of 0.9 mm and was developed specifically for
      this use. This type of ACM has been used in hundreds of surgeries and has been found to be
      both effective and safe.

      This procedure has 4 clear advantages:

        1. The implementation of three corneal incisions, 1.1 mm wide with an angle of
           approximately 120 degrees between them - neutrality regarding astigmatism versus the
           Biaxial-MICS.

        2. This procedure does not require any special medical instruments, for example; new phaco
           instruments which are specifically adapted for the MICS approach at the cost of tens of
           thousands of dollars.

        3. This procedure allows a free use of the surgeon's second hand.

        4. A fixed intraocular infusion keeps the intraocular pressure (IOP) and anterior chamber
           volume constant and stable.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal temperature</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Continuous corneal temperature will be measured during cataract surgery using an infra red thermal imaging system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior chamber stability</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Anterior chamber stability will be accessed during cataract surgery by the surgeon and post op by two different observers using surgery video record.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Tri-MICS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Phaco</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification using an ACM as the sole fluid source</intervention_name>
    <description>A Tri-MICS system will be used with a sleeveless Kelman 20G tip through a 1.1mm CCI. A specialized 19G anterior chamber maintainer, with thin walls and a large internal diameter of 0.9mm will be inserted through a 1.1mm CCI.</description>
    <arm_group_label>Tri-MICS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Phaco</intervention_name>
    <description>a conventional Phaco with sleeved Kelman 20G tip, through a 2.4mm CCI</description>
    <arm_group_label>Conventional Phaco</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral Cataract

          -  Ability to understand and sign on an inform consent form.

          -  whiling to undergo bilateral cataract surgery.

        Exclusion Criteria:

          -  Mature Cataract

          -  PXF

          -  Uveitis

          -  Corneal Pathology

          -  Endothelial cell density&lt;1500 cells/mm

          -  Glaucoma

          -  Extreme Hyperopia / shallow anterior chamber

          -  Extreme Myopia

          -  s/p Ophthalmic Trauma / Surgery

          -  Allergy to Penicillin / IOD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adi Abulafia, MD</last_name>
      <phone>+972-9-7472154</phone>
      <email>adi.abulafia@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yafit Steren, SC</last_name>
      <phone>+972-9-7471707</phone>
      <email>yafit.steren@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ehud Assia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shay Ofir, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Avner Belkin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noa Gefen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adi Michaeli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2012</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Abulafia Adi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>TRI-MICS</keyword>
  <keyword>ACM</keyword>
  <keyword>MICS</keyword>
  <keyword>phacoemulsification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

